Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05521412 |
|---|---|
| Brief Title: | EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (VIOLET) |
| First Submitted : | August 22, 2022 |
| First Submitted that Met QC Criteria : | August 26, 2022 |
| First Posted : | August 30, 2022 |
| Last Update Submitted that Met QC Criteria : | March 14, 2024 |
| Last Update Posted : | March 18, 2024 |